Business Context and Reporting Period
This Form 6-K filing by GlaxoSmithKline plc covers the period ending December 23, 2003. The report serves as a notification of changes in directors' interests in the company's Ordinary Shares.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This document is limited to reporting specific equity transactions and does not contain financial performance data.
Material Changes
The only material change reported is a transaction involving the GlaxoSmithKline Employee Trust ("GSK Trust"). On December 22, 2003, Abacus (GSK) Trustees Limited transferred 1,874 Ordinary shares to a participant in the SmithKline Beecham Employee Share Option Plan 1991.
Management Commentary and Risks
The filing notes that the GSK Trust is a discretionary trust where all current and former employees are potential beneficiaries. Consequently, Directors Dr. J-P Garnier and Mr. J D Coombe hold an interest in the shares held by the trust in the same capacity as other employees. No other risks, contingencies, or unusual items are disclosed in this text.
Investor Verification Points
- Verify the total number of shares held by the GSK Trust following the transfer of 1,874 shares.
- Confirm the specific identity of the employee participant who received the shares under the 1991 Share Option Plan.
- Review the full annual report (Form 20-F) for comprehensive financial metrics, as this 6-K filing does not contain them.